Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...
Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.
Eczema is a group of conditions that make your skin inflamed or irritated. The most common type is atopic dermatitis. Conditions That Can Look Like Eczema but Aren’t Your dermatologist or ...
Diagnosis, treatment, lifestyle changes ... Hand dermatitis (HD), also known as hand eczema, is a common dermatologic disorder (Warshaw, Lee, & Storrs, 2003). It is a frequent problem among ...